Company’s revenue grew 28% to ₹1,432 crore, while EBITDA increased 17.5% to ₹288 crore. EBITDA margin, however, narrowed to 20% from 22% a year earlier.
Alongside its earnings, the board approved a ₹70 crore capital expenditure to set up India’s first Carbon Nano Tubes (CNT) manufacturing facility in West Bengal using the company’s in-house developed technology.
The plant will have an annual capacity of 200 metric tonnes and is expected to be commissioned by Q4FY27, said the company. The project will be funded through internal accruals.
The company said it has developed the CNT technology through its own research and development efforts. Carbon Nano Tubes are used in applications including lithium-ion batteries, electronics, semiconductors, conductive films, sensors, advanced composites, coatings, construction and aerospace.
Himadri also announced plans to enter the Super Speciality Carbon Black (SSCB) segment by converting around 6,000 MTPA from its existing carbon black stream. The project involves a proposed ₹170 crore investment and is targeted for commissioning by Q4FY28.
Commenting on the performance, Chairman and Managing Director Anurag Choudhary said the company’s quarterly results were supported by an improved product mix across its core businesses and continued ramp-up in speciality materials despite the geopolitical backdrop.
The company added that its Anthraquinone and Carbazole project remains on schedule. The facility will have a planned capacity of 5,300 MTPA, with the first phase of 2,600 MTPA targeted for commissioning in Q2FY27 and the remaining 2,700 MTPA in Q2FY28.
Himadri said the project is expected to reduce India’s dependence on imports in dyes and pigments while expanding its speciality chemicals portfolio.
Shares of Himadri Speciality Chemical Ltd ended at ₹680.40 on the NSE on July 15, gaining ₹9.00, or 1.34%, from the previous close.
Also Read: ‘This has to stop’: Former tech CEO lashes out at AI-led tech layoffs
(Edited by : Prashant)
First Published: Jul 15, 2026 6:25 PM IST
